Chemoembolization and radioembolization for hepatocellular carcinoma

Riad Salem; Robert J. Lewandowski

doi:10.1016/j.cgh.2012.12.039

Chemoembolization and radioembolization for hepatocellular carcinoma

Riad Salem^*, Robert J. Lewandowski

^*Corresponding author for this work

Radiology

Research output: Contribution to journal › Article › peer-review

80 Scopus citations

Abstract

Hepatocellular carcinoma (HCC) continues to represent a major worldwide problem. Although treatments such as resection, transplantation, and ablation may provide a chance for a cure, these options are often precluded because of advanced disease presentation. Palliative treatments include transarterial embolization and systemic therapies. This review will summarize the state of the science for embolic therapies in HCC (conventional and drug-eluting chemoembolization, radioembolization) as well as discuss related topics including HCC staging, assessment of response, and ongoing clinical trials.

Original language	English (US)
Pages (from-to)	604-611
Number of pages	8
Journal	Clinical Gastroenterology and Hepatology
Volume	11
Issue number	6
DOIs	https://doi.org/10.1016/j.cgh.2012.12.039
State	Published - Jun 2013

Funding

Funding Riad Salem is funded in part by National Institutes of Health grant CA126809 .

Keywords

Chemoembolization
Hepatocellular Carcinoma
Radioembolization

ASJC Scopus subject areas

Gastroenterology
Hepatology

Access to Document

10.1016/j.cgh.2012.12.039

Cite this

@article{bedfecae042047c58f97169fc9cda5cd,

title = "Chemoembolization and radioembolization for hepatocellular carcinoma",

abstract = "Hepatocellular carcinoma (HCC) continues to represent a major worldwide problem. Although treatments such as resection, transplantation, and ablation may provide a chance for a cure, these options are often precluded because of advanced disease presentation. Palliative treatments include transarterial embolization and systemic therapies. This review will summarize the state of the science for embolic therapies in HCC (conventional and drug-eluting chemoembolization, radioembolization) as well as discuss related topics including HCC staging, assessment of response, and ongoing clinical trials.",

keywords = "Chemoembolization, Hepatocellular Carcinoma, Radioembolization",

author = "Riad Salem and Lewandowski, {Robert J.}",

note = "Funding Information: Funding Riad Salem is funded in part by National Institutes of Health grant CA126809 . ",

year = "2013",

month = jun,

doi = "10.1016/j.cgh.2012.12.039",

language = "English (US)",

volume = "11",

pages = "604--611",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders",

number = "6",

}

TY - JOUR

T1 - Chemoembolization and radioembolization for hepatocellular carcinoma

AU - Salem, Riad

AU - Lewandowski, Robert J.

N1 - Funding Information: Funding Riad Salem is funded in part by National Institutes of Health grant CA126809 .

PY - 2013/6

Y1 - 2013/6

N2 - Hepatocellular carcinoma (HCC) continues to represent a major worldwide problem. Although treatments such as resection, transplantation, and ablation may provide a chance for a cure, these options are often precluded because of advanced disease presentation. Palliative treatments include transarterial embolization and systemic therapies. This review will summarize the state of the science for embolic therapies in HCC (conventional and drug-eluting chemoembolization, radioembolization) as well as discuss related topics including HCC staging, assessment of response, and ongoing clinical trials.

AB - Hepatocellular carcinoma (HCC) continues to represent a major worldwide problem. Although treatments such as resection, transplantation, and ablation may provide a chance for a cure, these options are often precluded because of advanced disease presentation. Palliative treatments include transarterial embolization and systemic therapies. This review will summarize the state of the science for embolic therapies in HCC (conventional and drug-eluting chemoembolization, radioembolization) as well as discuss related topics including HCC staging, assessment of response, and ongoing clinical trials.

KW - Chemoembolization

KW - Hepatocellular Carcinoma

KW - Radioembolization

UR - http://www.scopus.com/inward/record.url?scp=84878132827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878132827&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2012.12.039

DO - 10.1016/j.cgh.2012.12.039

M3 - Article

C2 - 23357493

AN - SCOPUS:84878132827

SN - 1542-3565

VL - 11

SP - 604

EP - 611

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 6

ER -

Chemoembolization and radioembolization for hepatocellular carcinoma

Abstract

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this